DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo


company name or ticker

Arena And Vivus Ruined The FDA Approval Run Up For Orexigen

2 New Diet Drugs Coming Soon?

Orexigen Therapeutics and Novo Nordisk are close to bringing new diet drugs to market. But will doctors prescribe them?

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead

Belviq Sales See Holiday Dip - Still On Track

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr

A new weight loss pill from Orexigen will face stiff competition from Arena's Belviq and may soon have to compete against Novo Nordisk's Saxenda.

FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug

Orexigen and Takeda's Contrave has the right balance of efficacy and safety.

Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised

Orexigen's Contrave Approved: What It Means To Arena

FDA Approves Orexigen's Contrave For Obesity Treatment

Arena Pharmaceuticals - A Biotech Value Investment

See More Articles...